 zenith labs ltzen report 4th qtr loss zenith laboratories company report fourth quarter loss amount determined completion year end audit company elaborate quarter ended sept 30 1986 zenith reported loss 3451000 dlrs 16 cts share adjusted 1986 2for1 stock split company received food drug administration approval market cefadroxil generic version antibiotic domestic sales exceeding 50 mln dlrs 1986 zenith market drug questions relating applicability patents resolved